We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

CBQK:QSECommercial Bank (Q.S.C.) Analysis

Data as of 2026-06-16 - not real-time

QAR 4.27

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

The Commercial Bank (P.S.Q.C.) is trading at QAR 4.27, which sits just above its 20‑day SMA (4.19) but below the 50‑day (4.28) and 200‑day (4.39) averages, indicating a short‑term price weakness within a longer‑term bearish bias. Technical momentum shows a neutral RSI of 54 and a bullish MACD histogram (+0.016) despite a bearish trend direction, while volume is trending downwards, suggesting diminishing buying pressure. On the valuation side, the stock trades at a forward PE of 6.7 versus an industry average of 16.9, and a price‑to‑book of 0.66, positioning it as undervalued relative to peers. The dividend yield of 7.0% is attractive, but the sustainability flag is raised by negative operating cash flow (‑QAR 3.36 bn) and a high payout ratio of 65%, which could strain cash generation. Financially, the bank holds QAR 14.7 bn in cash against QAR 65.1 bn of debt, and a near‑zero beta (‑0.03) signals minimal market‑wide systematic risk, though the 30‑day volatility of 19.5% points to notable price swings. Overall, the company offers a value‑oriented entry with upside potential (~15% to the median analyst target of QAR 5.08) but carries medium‑term execution risk tied to cash‑flow generation and dividend sustainability.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near short‑term support at QAR 4.10
  • Decreasing volume indicating waning momentum
  • Neutral RSI and mixed MACD signals

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Undervalued multiples (PE ~9 vs industry ~17)
  • Attractive dividend yield despite cash‑flow concerns
  • Analyst price target upside of ~15%

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Sustainable dividend risk due to negative operating cash flow
  • Low systematic beta but elevated price volatility
  • Balanced exposure to Qatar and Turkey markets

Key Metrics & Analysis

Financial Health

Revenue Growth0.30%
Profit Margin53.32%
P/E Ratio9.3
ROE7.94%
ROA1.14%
P/B Ratio0.7
Op. Cash FlowQAR-3356748032
Industry P/E16.9

Technical Analysis

TrendBearish
RSI54.4
SupportQAR 4.10
ResistanceQAR 4.31
MA 20QAR 4.19
MA 50QAR 4.28
MA 200QAR 4.39
MACDBullish
VolumeDecreasing
Fear & Greed Index92.5

Valuation

Target PriceQAR 4.94
Upside/Downside15.73%
GradeUndervalued
TypeValue
Dividend Yield7.03%

Risk Assessment

Beta-0.03
Volatility19.51%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.